Concurrent primary hyperparathyroidism and humoral hypercalcemia of malignancy in a patient with multiple endocrine neoplasia type 1

Pancreas

Volumn 40, Issue 4, 2011, Pages 634-637

  Milanesi, Anna ^a   Yu, Run ^a   Geller, Stephen A ^b   Burton, Doug ^c   Deftos, Leonard J ^c   Wolin, Edward M ^b  

^a Samuel Oschin Comprehensive Cancer Institute   (United States)

^b CEDARS SINAI MEDICAL CENTER   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

hypercalcemia; multiple endocrine neoplasia 1; pancreatic neuroendocrine tumor; parathyroid hormone; Parathyroid hormoneYrelated peptide; primary hyperparathyroidism

Indexed keywords

ANTINEOPLASTIC AGENT; CALCIUM; KI 67 ANTIGEN; OCTREOTIDE; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE RELATED PROTEIN; PENTETREOTIDE IN 111; PHOSPHATE;

ADULT; ARTICLE; CALCIUM BLOOD LEVEL; CASE REPORT; CHEMOEMBOLIZATION; DISEASE SEVERITY; FATIGUE; FLUID RESUSCITATION; FOLLOW UP; HUMAN; HYPERCALCEMIA; HYPOPHOSPHATEMIA; IMMUNOHISTOCHEMISTRY; INSULIN DEPENDENT DIABETES MELLITUS; LIVER METASTASIS; LIVER NECROSIS; LIVER SCINTISCANNING; MALE; MULTIPLE ENDOCRINE NEOPLASIA; NEUROENDOCRINE TUMOR; NUCLEAR MAGNETIC RESONANCE IMAGING; PANCREAS CARCINOMA; PANCREAS RESECTION; PARATHYROID ADENOMA; PARATHYROID HORMONE BLOOD LEVEL; PARATHYROIDECTOMY; PHOSPHATE BLOOD LEVEL; PRIMARY HYPERPARATHYROIDISM; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; SPLENECTOMY; THYROID SCINTISCANNING; TREATMENT OUTCOME; WEAKNESS;

DIAGNOSIS, DIFFERENTIAL; HUMANS; HYPERCALCEMIA; HYPERPARATHYROIDISM, PRIMARY; MALE; MIDDLE AGED; MULTIPLE ENDOCRINE NEOPLASIA TYPE 1; NEUROENDOCRINE TUMORS; PANCREATIC NEOPLASMS; PARATHYROID HORMONE; PARATHYROID HORMONE-RELATED PROTEIN; PARATHYROID NEOPLASMS;

EID: 79955068199     PISSN: 08853177     EISSN: 15364828     Source Type: Journal    
DOI: 10.1097/MPA.0b013e318214f65e     Document Type: Article

References (11)

1. Barakat M, Ashrafian H, Todd JF, et al. Severe hypercalcaemia from secretion of parathyroid hormone-related peptide. Lancet Oncol. 2004; 5:633-635. (Pubitemid 39303131)
2. Bouvet M, Nardin SR, Burton DW, et al. Human pancreatic adenocarcinomas express parathyroid hormone-related protein. J Clin Endocrinol Metab. 2001; 86:310-316. (Pubitemid 32109811)
3. Burton DW, Brandt DW, Deftos LJ. Parathyroid hormone-related protein in the cardiovascular system. Endocrinology. 1994; 135: 253-261. (Pubitemid 24203824)
4. Suva LJ, Winslow GA, Wettenhall RE, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987; 237:893-896. (Pubitemid 17128278)
5. Burtis WJ, Brady TG, Orloff JJ, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med. 1990; 322:1106-1112. (Pubitemid 20149527)
6. Srirajaskanthan R, McStay M, Toumpanakis C, et al. Parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumours: case series and literature review. Neuroendocrinology. 2009; 89:48-55.
7. Burgess JR, Wilkinson S, Lowenthal RM. Parathyroid hormone related protein (PTHrP) mediated hypercalcaemia complicating enteropancreatic malignancy in multiple endocrine neoplasia type 1 (MEN 1). Aust N Z J Med. 2000; 30:280-281. (Pubitemid 30304489)
8. Wu TJ, Lin CL, Taylor RL, et al. Increased parathyroid hormone-related peptide in patients with hypercalcemia associated with islet cell carcinoma. Mayo Clin Proc. 1997; 72:1111-1115. (Pubitemid 27528320)
9. Clemens P, Gregor M, Lamberts R. Pancreatic neuroendocrine tumor with extensive vascularisation and parathyroid hormone-related protein (PTHrP)-associated hypercalcemia of malignancy. Exp Clin Endocrinol Diabetes. 2001; 109:378-385. (Pubitemid 32977420)
10. Mussig K, Petersenn S, Wehrmann M, et al. Somatostatin receptor expression in a parathyroid hormone-related peptide-secreting pancreatic neuroendocrine tumor causing severe hypercalcaemia. Eur J Gastroenterol Hepatol. 2007; 19:719-723. (Pubitemid 47067072)
11. Tarver DS, Birch SJ. Case report: life-threatening hypercalcaemia secondary to pancreatic tumor secreting parathyroid hormone-related protein - successful control by hepatic arterial embolization. Clin Radiol. 1992; 46:204-205.